Drive the Future Beyond Healthcare

This is a public journal available to anyone who is interested in learning more about medical advances that have improved patient care. Articles, research, and other contributed material are for the purpose of educating and providing a more individualized approach to medicine.

We are a 501 (c) (3) non-profit providing information to patients, providers and caregivers for health and wellness!

Member Log in

Let's get together & share our services

1st international symposium

We are calling patients, families and providers to join us in organizing the 1st International Symposium. We are looking for help in logistics,

Click here to let us know how you want to help.

Neurology Dr. Peter G. Bernard, Washington, DC

Cardiology Dr. Joginder S. Soni. Turlock, CA

Dr. Michael I. Weintraub. Briarcliff Manor, NY

07. Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

AUTHORS:
DePace NL, Santos, L; Munoz, R; Acosta CR, DePace Jr. NL, Kaczmarski K, Ahmad, G; Verma,
A; Goldis M, Colombo J.

Drive the Future Beyond Healthcare

Member Log in

Let's get together & share our services

1st international symposium

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

AUTHORS

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

AUTHORS

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

AUTHORS

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

AUTHORS

Volume: 1 - Year: 2022

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

01.

Introduction to the Inaugural Edition of the Journal of Individualized Medicine and Therapies

02.

Hypermobility: An Autonomic Conundrum Like Diabetes

03.

Ehlers-Danlos Syndrome and Autonomic Dysregulation: “The Invisible Woman Has Significant Pathology and Morbidity.”

04.

Ehlers Danlos Syndrome and Hypermobility: A Rheumatologist’s Perspective

05.

Hypermobility/Ehlers-Danlos Syndrome and the Parasympathetic and Sympathetic Nervous Systems

06.

Hypermobility and Ehlers-Danlos Syndrome Symptoms are Explained by Abnormal Sympathetic Responses to Head-Up Postural Change

07.

Abnormal Parasympathetic Responses to Stress Exacerbate Hypermobility and Ehlers-Danlos Syndrome Symptoms

08.

Review: The critical deleterious cardiac effects of the sympathetic nervous system in congestive heart failure and a novel new therapeutic approach for correction.

09.

Prolonged, Untreated Autonomic Dysfunction May Ultimately Lead to Heart Failure.

10.

COVID-19 Reminds Us How Vital Knowledge And Treatment Of Patients’ Autonomic Nervous System Abnormalities Are In Cardiovascular Disease

11.

Coronavirus induces oxidative stress leading to autonomic dysfunction often with delayed symptom onset

12.

Oral Vasoactive Medications: A Review of Midodrine, Droxidopa and Pseudoephedrine

Volume: 2 - Year: 2023

01.

A Review and Understanding of Cranial Anatomy and Parasympathetic Physiology

02.

The Effects of Neurofeedback on the Parasympathetic and Sympathetic Nervous Systems

03.

Is Integrative Medicine Missing Something?

04.

Long-COVID, PTSD and EDS/Hypermobility Have Common Parasympathetic and Sympathetic Dysfunctions Causing Poor Cerebral and Coronary Perfusion

05.

Does Complex Care Have to be That Complex? Perhaps More Information is Needed?

06.

The Importance of Parasympathetic Excess and Why “The Foot on the Brakes” is a Primary Dysautonomia

07.

Why Only Manage POTS?!? POTS MAY BE CURED!! A Review

08.

Why Only Manage Anxiety?!? ANXIETY MAY BE CURED!! A Review

Services

Resources